In a 21-week double-blinded, placebo-controlled pilot study, 20 CeD patients inoculated with L3i or placebo and subjected to a 5-day oral wheat tolerance challenge displayed immune responses, with decreased inflammatory cytokines and a weak trend towards attenuation of a response to gluten [ 118 , 119 ].
1
—
—